SCHEMBL6707625

SCHEMBL6707625

O=C(Cc1ccc2ccccc2c1)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3noc(=O)[nH]3)[nH]c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 1/20 0.41
MAPK10 P53779 1/20 0.41
RIOK2 Q9BVS4 1/20 0.41
HDAC3 O15379 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
NR1H4 Q96RI1 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NPY5R Q15761 1/20 0.40
GRIK1 P39086 1/20 0.40
EGLN1 Q9GZT9 1/20 0.39
PARP14 Q460N5 2/20 0.39
PLCG2 P16885 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
TRPV1 Q8NER1 1/20 0.36
NHERF1 O14745 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713394 0.94 PARP14 (0.42) HDAC2MEN1KMT2AGRIK1PARP14
SCHEMBL6709861 0.93 GRIK1 (0.41) MEN1KMT2AGRIK1PARP14PLCG2
SCHEMBL6708770 0.93 GRIK1 (0.41) HDAC1MEN1KMT2AGRIK1PARP14
SCHEMBL6711895 0.92 PARP14 (0.44) MEN1KMT2AGRIK1PARP14PLCG2
SCHEMBL6708772 0.92 PARP14 (0.42) HDAC1NR1H4MEN1KMT2AGRIK1
SCHEMBL6712528 0.91 GRIK1 (0.39) GRIK1PARP14PLCG2NHERF1NLRP3
SCHEMBL6707991 0.91 PTK2B (0.41) MEN1KMT2AGRIK1PARP14PLCG2
SCHEMBL6713651 0.91 MEN1 (0.44) RIOK2HDAC3HDAC1HDAC2HDAC10
SCHEMBL6710325 0.91 RXFP1 (0.40) HDAC3HDAC1HDAC2MEN1KMT2A
SCHEMBL6707707 0.90 KMT2A (0.46) MEN1KMT2AGRIK1PARP14LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GSK3A 4158/4885MAPK10 2947/4885RIOK2 4127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.